Status: Not yet recruiting
Combination CurQD and Vedolizumab in Ulcerative Colitis
The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-active pill), in combination with vedolizumab prescribed as standard of care for patients with ulcerative colitis (UC)..
Participants needed: 160
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Ryan C UngaroUpdated: Jun 24, 2026Locations: 1
Eligibility criteria
Age 18 to 80 years old (inclusive) at time of consent [+9]
Diagnosis of inflammatory bowel disease unclassified (IBD-U) or Crohn's colitis [+27]